勘误表

ERRATA CORRIGE.

出版信息

J Prev Med Hyg. 2021 Apr 29;62(1):E249-E260. doi: 10.15167/2421-4248/jpmh2021.62.1.1832. eCollection 2021 Mar.

DOI:10.15167/2421-4248/jpmh2021.62.1.1832

PMID:34322644

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8283635/

Abstract

[This corrects the article on p. E530-E541 in vol. 61, PMID: 33628957.].

摘要

[这更正了第61卷第E530 - E541页上的文章， PMID: 33628957。]

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d461/8283635/8d888a795523/jpmh-2021-01-e249-g001.jpg

相似文献

ERRATA CORRIGE.勘误表

J Prev Med Hyg. 2021 Apr 29;62(1):E249-E260. doi: 10.15167/2421-4248/jpmh2021.62.1.1832. eCollection 2021 Mar.

Reduced-antigen, combined diphtheria, tetanus and acellular pertussis vaccine, adsorbed (Boostrix®): a review of its properties and use as a single-dose booster immunization.吸附无细胞百白破灭活、全细胞百日咳和破伤风联合疫苗（Boostrix®）：作为单剂加强免疫的特性和用途介绍。

Drugs. 2012 Sep 10;72(13):1765-91. doi: 10.2165/11209630-000000000-00000.

Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults.成人接种含低剂量抗原的白喉-破伤风-无细胞百日咳疫苗（Tdap）初免加强后 9 年，抗体持久性、安全性和免疫原性。

Vaccine. 2018 Oct 8;36(42):6325-6333. doi: 10.1016/j.vaccine.2018.08.051. Epub 2018 Sep 7.

Decennial administration in young adults of a reduced-antigen content diphtheria, tetanus, acellular pertussis vaccine containing two different concentrations of aluminium.对年轻成年人进行为期十年的含有两种不同铝浓度的低抗原含量白喉、破伤风、无细胞百日咳疫苗接种管理。

Vaccine. 2015 Jun 12;33(26):3026-34. doi: 10.1016/j.vaccine.2014.10.049. Epub 2015 Jan 19.

A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults.一项关于破伤风、白喉和无细胞百日咳（Tdap）疫苗与破伤风和白喉（Td）疫苗作为健康成年人加强针时的安全性和免疫原性的随机、双盲、非劣效性临床试验比较。

Vaccine. 2012 Aug 10;30(37):5464-71. doi: 10.1016/j.vaccine.2012.06.073. Epub 2012 Jul 6.

Immunogenicity and antibody persistence of diphteria-tetanus-acellular pertussis vaccination in adolescents and adults: a systematic review of the literature showed different responses to the available vaccines.青少年和成人中白喉-破伤风-无细胞百日咳疫苗的免疫原性和抗体持久性：一项文献系统综述显示，对现有疫苗的反应各异。

J Prev Med Hyg. 2021 Jan 14;61(4):E530-E541. doi: 10.15167/2421-4248/jpmh2020.61.4.1832. eCollection 2020 Dec.

Immunogenicity of reduced antigen content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.抗原含量降低的破伤风-白喉-无细胞百日咳疫苗作为含无细胞百日咳疫苗的第六剂在青少年中的免疫原性。

Vaccine. 2007 Jul 20;25(29):5248-52. doi: 10.1016/j.vaccine.2007.05.012. Epub 2007 Jun 4.

Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).预防青少年破伤风、白喉和百日咳：破伤风类毒素、白喉类毒素含量降低的无细胞百日咳疫苗的使用——免疫实践咨询委员会（ACIP）的建议

MMWR Recomm Rep. 2006 Mar 24;55(RR-3):1-34.

Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine in the USA.美国青少年和成人配方联合破伤风、白喉和 5 组分无细胞百日咳疫苗加强免疫后 10 年的体液免疫。

Vaccine. 2018 Apr 19;36(17):2282-2287. doi: 10.1016/j.vaccine.2018.03.029. Epub 2018 Mar 21.

Immunogenicity, safety, and antibody persistence at 3, 5, and 10 years postvaccination in adolescents randomized to booster immunization with a combined tetanus, diphtheria, 5-component acellular pertussis, and inactivated poliomyelitis vaccine administered with a hepatitis B virus vaccine concurrently or 1 month apart.在随机接受破伤风、白喉、五组分无细胞百日咳和灭活脊髓灰质炎联合疫苗与乙肝病毒疫苗同时接种或间隔1个月加强免疫的青少年中，接种疫苗后3年、5年和10年的免疫原性、安全性及抗体持久性。

Clin Vaccine Immunol. 2015 Mar;22(3):282-90. doi: 10.1128/CVI.00682-14. Epub 2014 Dec 24.

本文引用的文献

Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III, open-label study.在健康俄罗斯参与者中作为加强疫苗剂量接种的联合低抗原含量白喉-破伤风-无细胞百日咳疫苗的免疫原性、安全性和反应原性：一项III期开放标签研究

Hum Vaccin Immunother. 2021 Mar 4;17(3):723-730. doi: 10.1080/21645515.2020.1796423. Epub 2020 Aug 26.

Seroprevalence of antibodies against diphtheria, tetanus, and pertussis among healthy Thai adolescents.泰国健康青少年对白喉、破伤风和无细胞百日咳的抗体血清流行率。

Int J Infect Dis. 2020 Jul;96:422-430. doi: 10.1016/j.ijid.2020.04.088. Epub 2020 May 6.

Reactogenicity and immunogenicity of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant and nonpregnant women.破伤风类毒素、白喉类毒素和无细胞百日咳疫苗（Tdap）在孕妇和非孕妇中的反应原性和免疫原性。

Vaccine. 2018 Oct 8;36(42):6354-6360. doi: 10.1016/j.vaccine.2018.07.012. Epub 2018 Sep 13.

Effect of Tdap upon antibody response to meningococcal polysaccharide when administered before, with or after the quadrivalent meningococcal TT-conjugate vaccine (coadministered with the 13-valent pneumococcal CRM197-conjugate vaccine) in adult Hajj pilgrims: A randomised controlled trial.Tdap 对在接种四价脑膜炎球菌结合疫苗（与 13 价肺炎球菌 CRM197 结合疫苗联合接种）前、同时或之后接种的成人朝觐者对脑膜炎球菌多糖的抗体应答的影响：一项随机对照试验。

Vaccine. 2018 Jul 5;36(29):4375-4382. doi: 10.1016/j.vaccine.2018.04.033. Epub 2018 Jun 5.

Vaccine. 2018 Apr 19;36(17):2282-2287. doi: 10.1016/j.vaccine.2018.03.029. Epub 2018 Mar 21.

Randomized Controlled Trial of the Safety and Immunogenicity of Revaccination With Tetanus-Diphtheria-Acellular Pertussis Vaccine (Tdap) in Adults 10 Years After a Previous Dose.10 年前接种过一剂破伤风、白喉、无细胞百日咳疫苗（Tdap）的成人再次接种 Tdap 的安全性和免疫原性随机对照试验。

J Pediatric Infect Dis Soc. 2019 May 11;8(2):105-114. doi: 10.1093/jpids/pix113.

Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults.一种破伤风、白喉、重组无细胞百日咳联合疫苗（TdaP）在泰国健康成年人中的安全性和免疫原性。

Hum Vaccin Immunother. 2017 Jan 2;13(1):136-143. doi: 10.1080/21645515.2016.1234555. Epub 2016 Sep 29.

Pertussis: Microbiology, Disease, Treatment, and Prevention.百日咳：微生物学、疾病、治疗与预防

Clin Microbiol Rev. 2016 Jul;29(3):449-86. doi: 10.1128/CMR.00083-15.

A Phase 2, Randomized, Active-controlled, Observer-blinded Study to Assess the Immunogenicity, Tolerability and Safety of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered With Tetanus, Diphtheria and Acellular Pertussis Vaccine and Serogroup A, C, Y and W-135 Meningococcal Conjugate Vaccine in Healthy US Adolescents.一项2期随机、活性对照、观察者盲法研究，旨在评估二价重组脂蛋白2086（一种B群脑膜炎球菌疫苗）与破伤风、白喉和无细胞百日咳疫苗以及A、C、Y和W-135群脑膜炎球菌结合疫苗联合接种于健康美国青少年时的免疫原性、耐受性和安全性。

Pediatr Infect Dis J. 2016 Jun;35(6):673-82. doi: 10.1097/INF.0000000000001124.

Coadministration of a 9-Valent Human Papillomavirus Vaccine With Meningococcal and Tdap Vaccines.九价人乳头瘤病毒疫苗与脑膜炎球菌和 Tdap 联合疫苗的使用。

Pediatrics. 2015 Sep;136(3):e563-72. doi: 10.1542/peds.2014-4199. Epub 2015 Aug 3.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

勘误表

ERRATA CORRIGE.

出版信息

相似文献

本文引用的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

本文引用的文献